| Dec 18, 2025 |
Dec 19, 2025 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP, CSO |
Sell |
46.3
|
-710
|
-4.67%
|
✗
|
$31.6K |
| Aug 25, 2025 |
Aug 27, 2025 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP, CSO |
Sell |
46.3
|
-581
|
-4.06%
|
✗
|
$24.1K |
| Mar 5, 2025 |
Mar 5, 2025 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP, CSO |
Sell |
46.3
|
-1,485
|
-10.47%
|
✗
|
$49.1K |
| Feb 21, 2025 |
Feb 24, 2025 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP, CSO |
Sell |
91.3
|
+2,390
|
20.26%
|
✗
|
$33.7K |
| Feb 4, 2025 |
Feb 5, 2025 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP, CSO |
Sell |
20.0
|
-9,477
|
-48.29%
|
✗
|
$376.2K |
| Jan 27, 2025 |
Jan 29, 2025 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP, CSO |
Sell |
22.5
|
-3,273
|
-13.89%
|
✗
|
$129.7K |
| Dec 3, 2024 |
Dec 4, 2024 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP, CSO |
Sell |
20.0
|
-21,495
|
-52.62%
|
✗
|
$788.4K |
| Aug 20, 2024 |
Aug 20, 2024 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP, CSO |
Sell |
46.3
|
-572
|
-5.58%
|
✗
|
$16.9K |
| Mar 21, 2024 |
Mar 25, 2024 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP, CSO |
Sell |
7.5
|
-14,491
|
-62.84%
|
✓
|
$511.7K |
| Mar 20, 2024 |
Mar 22, 2024 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP, CSO |
Sell |
41.3
|
-400
|
-4.46%
|
✓
|
$14.1K |
| Mar 19, 2024 |
Mar 21, 2024 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP, CSO |
Sell |
7.5
|
-12,364
|
-59.06%
|
✓
|
$436.6K |
| Mar 13, 2024 |
Mar 15, 2024 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP, CSO |
Sell |
5.0
|
-62,366
|
-78.44%
|
✓
|
$2.1M |
| Mar 12, 2024 |
Mar 14, 2024 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP, CSO |
Sell |
10.0
|
-3,884
|
-31.19%
|
✓
|
$128.1K |
| Feb 26, 2024 |
Feb 28, 2024 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP, CSO |
Sell |
10.0
|
-5,000
|
-36.85%
|
✓
|
$151.1K |
| Feb 23, 2024 |
Feb 27, 2024 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP, CSO |
Sell |
86.3
|
+612
|
7.69%
|
✗
|
$18.5K |
| Feb 22, 2024 |
Feb 26, 2024 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP, CSO |
Sell |
83.8
|
+378
|
4.99%
|
✗
|
$10.4K |
| Sep 7, 2023 |
Sep 7, 2023 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP, CSO |
Sell |
46.3
|
-1,182
|
-14.16%
|
✗
|
$37.9K |
| Jan 17, 2023 |
Jan 19, 2023 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP, CSO |
Sell |
10.0
|
-4,826
|
-74.59%
|
✓
|
$192.6K |
| Jan 6, 2023 |
Jan 9, 2023 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP, CSO |
Sell |
33.8
|
-174
|
-9.57%
|
✓
|
$6.9K |
| Dec 1, 2022 |
Dec 2, 2022 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP, CSO |
Sell |
10.0
|
-5,000
|
-75.26%
|
✓
|
$187.4K |
| Nov 11, 2022 |
Nov 15, 2022 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP, CSO |
Sell |
10.0
|
-6,800
|
-80.53%
|
✓
|
$237.7K |
| Nov 9, 2022 |
Nov 14, 2022 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP, CSO |
Sell |
13.8
|
-700
|
-29.86%
|
✓
|
$24.5K |
| Jun 28, 2018 |
Jun 29, 2018 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP, CSO |
Sell |
7.5
|
-7,795
|
-100.00%
|
✓
|
$467.1K |
| Jun 21, 2018 |
Jun 22, 2018 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP, CSO |
Sell |
7.5
|
-7,205
|
-49.00%
|
✓
|
$432.3K |
| May 15, 2018 |
May 16, 2018 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP, CSO |
Sell |
7.5
|
-7,868
|
-34.41%
|
✓
|
$455.8K |
| May 10, 2018 |
May 14, 2018 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP, CSO |
Sell |
5.0
|
-67,132
|
-62.66%
|
✓
|
$3.6M |
| Jan 22, 2018 |
Jan 22, 2018 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP, CSO |
Sell |
7.5
|
-20,000
|
-61.54%
|
✓
|
$960.7K |
| Jan 17, 2018 |
Jan 17, 2018 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP, CSO |
Sell |
7.5
|
-20,000
|
-61.54%
|
✓
|
$899.5K |
| Sep 8, 2017 |
Sep 11, 2017 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr VP of IP, CSO |
Sell |
10.0
|
-5,000
|
-28.57%
|
✓
|
$249.3K |
| Aug 16, 2017 |
Aug 16, 2017 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr.VP of IP, CSO |
Sell |
20.0
|
-3,709
|
-17.49%
|
✓
|
$167.8K |
| Jul 12, 2017 |
Jul 14, 2017 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP, CSO |
Sell |
25.0
|
-3,735
|
-14.97%
|
✓
|
$167.7K |
| Jun 23, 2017 |
Jun 27, 2017 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP, CSO |
Sell |
28.8
|
-2,556
|
-9.29%
|
✓
|
$114.8K |
| Jun 2, 2017 |
Jun 5, 2017 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP, CSO |
Sell |
7.5
|
-10,000
|
-26.67%
|
✓
|
$398.6K |
| May 26, 2017 |
May 30, 2017 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP, CSO |
Sell |
32.5
|
-2,500
|
-6.25%
|
✓
|
$89.8K |
| May 24, 2017 |
May 25, 2017 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP, CSO |
Sell |
25.0
|
-5,500
|
-12.09%
|
✓
|
$192K |
| Apr 24, 2017 |
Apr 24, 2017 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP, CSO |
Sell |
12.5
|
-11,806
|
-20.60%
|
✓
|
$384.8K |
| Apr 11, 2016 |
Apr 12, 2016 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP, CSO |
Sell |
7.5
|
-30,762
|
-34.93%
|
✓
|
$507.2K |
| Dec 8, 2015 |
Dec 10, 2015 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP, CSO |
Sell |
25.0
|
-14,238
|
-13.92%
|
✓
|
$212.1K |
| Nov 4, 2015 |
Nov 6, 2015 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP, CSO |
Sell |
37.5
|
-5,000
|
-4.66%
|
✓
|
$99.5K |
| Aug 19, 2013 |
Aug 21, 2013 |
SUPERNUS PHARMACEUTICALS, INC.
|
Sr. VP of IP; CSO |
Sell |
41.3
|
-2,285
|
-4.22%
|
✓
|
$18.8K |